Home › Funds › SPHERA FUNDS MANAGEMENT LTD. › OVID
SPHERA FUNDS MANAGEMENT LTD. position in OVID
OVID THERAPEUTICS INC · Health Care
SPHERA FUNDS MANAGEMENT LTD. reported holding 1,600,000 shares of OVID (OVID THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.0M, representing 0.61% of its reported portfolio and ranking #50 among its reported holdings. SPHERA FUNDS MANAGEMENT LTD. has disclosed OVID holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How SPHERA FUNDS MANAGEMENT LTD.'s OVID position evolved
SPHERA FUNDS MANAGEMENT LTD. first disclosed a stake in OVID in Q1 2026 at 1,622,828 shares (US$3.6M). The position peaked in Q3 2026 at 1,600,000 shares, worth US$4.0M. Across 3 filings, SPHERA FUNDS MANAGEMENT LTD. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,600,000 shares valued at US$4.0M — an increase of 247,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.62M | $3.60M | New |
| Q2 2026 | 1.35M | $3.64M | Reduce |
| Q3 2026 | 1.60M | $3.98M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OVID and 13F data
OVID (OVID THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in OVID — the largest reported positions include Affinity Asset Advisors, LLC (US$25.3M), SILVERARC CAPITAL MANAGEMENT, LLC (US$14.8M), ADAR1 Capital Management, LLC (US$11.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OVID
- Affinity Asset Advisors, LLC 10.14M sh · $25.26M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 5.95M sh · $14.82M · Q3 2026
- ADAR1 Capital Management, LLC 4.56M sh · $11.36M · Q3 2026
- Ikarian Capital, LLC 2.12M sh · $5.28M · Q3 2026
- Rosalind Advisors, Inc. 1.11M sh · $2.76M · Q3 2026
- Propel Bio Management, LLC 1.02M sh · $2.54M · Q3 2026
- Sio Capital Management, LLC 1.01M sh · $2.50M · Q3 2026
More on SPHERA FUNDS MANAGEMENT LTD.
FAQ
How long has SPHERA FUNDS MANAGEMENT LTD. held OVID?
SPHERA FUNDS MANAGEMENT LTD. has disclosed OVID holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is SPHERA FUNDS MANAGEMENT LTD.'s current position in OVID?
As of Q3 2026, SPHERA FUNDS MANAGEMENT LTD. holds 1.60M shares of OVID (OVID THERAPEUTICS INC), valued at $3.98M, representing 0.61% of its reported portfolio and ranking #50.
Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling OVID?
In the latest 13F filing (Q3 2026), SPHERA FUNDS MANAGEMENT LTD. increased its position in OVID. The position peaked in Q3 2026 at 1.60M shares.
Which other funds hold OVID?
Other major institutional holders of OVID include Affinity Asset Advisors, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, ADAR1 Capital Management, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.